Autonomix Medical stockholders approve reverse split, expanded equity plan at annual meeting

Autonomix Medical, Inc.

All five director nominees elected; Forvis Mazars ratified as auditor for FY ending Mar 2026.
Reverse stock split authorized at ratio of 1-for-2 to 1-for-25, board discretion for one year.
Amended and restated 2023 Equity Incentive Plan approved, increasing authorized shares by 1.9M to ~2.27M.
Issuance of >20% of outstanding common stock to Lincoln Park Capital Fund, LLC approved.
Total shares voted 2,871,639 (48% of outstanding) constituting a quorum.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.